FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1844852936> ?p ?o ?g. }

• W1844852936 abstract "Lung cancer is the leading cause of cancer mortality, despite development of therapeutic strategies. Altered expression of microRNAs(miRNAs) in human malignancies have been well recognized as diagnostic and prognostic indicators, including lung cancer. This study aims to delineate the clinicopathologic significance of three unique miRNAs in adenocarcinoma according to major sensitive EGFR mutation status. One-hundred and three formalin-fixed paraffin-embedded (FFPE) tissues were collected from lung adenocarcinoma patients who underwent surgery and epidermal growth factor receptor (EGFR) mutation study. The samples were divided into three groups which include EGFR mutation in exons 19 and 21 and wild type. Some representative cases from each group were profiled using commercial miRNA microarray plates. Three significant miRNAs were selected and they were validated by quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR), using collective cases of FFPE samples. We identified three microRNAs (miR-34c, miR-183, and miR-210) which showed significantly altered expression in all groups of lung adenocarcinoma by microarray study. Compared to normal control lung tissue, down-regulation of miR-34c and up-regulation of miR-183 and miR-210 were identified in caner groups (p < 0.05 for each). We validated the expression of three miRNAs by qRT-PCR. Expression levels of miR-34c, miR-183, and miR-210 were significantly different between normal control group and cancer groups (p = 0.034, <0.000, and 0.036, respectively). Moreover, expression level of miR-183 was significantly higher in EGFR mutation groups than wild type group (p = 0.028). Higher expression levels of three miRNAs were positively related to poor tumor differentiation. Increased expression of miR-183 was positively associated with lymphovascular invasion (p = 0.037). Aberrant expression of miR-210 was independently associated with T stage (p = 0.019), and TNM stage (p = 0.007). However, there was noted a limited statistical significance. In EGFR exon 19 mutation group, miR-34c high expression group showed poor overall survival than low expression one by univariate Kaplan-Meier method. (p = 0.035). Here, we show that miR-34c may act as a potential tumor suppressor gene and miR-183 and miR-210 have a potential oncogenic role in pulmonary adenocarcinoma. This study also suggests different miRNA expression between EGFR mutation group and wild type group. Consequently, further studies of the biology of miRNAs may lead to diagnostic and prognostic biomarkers in pulmonary adenocarcinoma." @default.
• W1844852936 created "2016-06-24" @default.
• W1844852936 creator A5011356826 @default.
• W1844852936 creator A5026756619 @default.
• W1844852936 creator A5055525358 @default.
• W1844852936 creator A5064783608 @default.
• W1844852936 creator A5087132038 @default.
• W1844852936 date "2015-07-12" @default.
• W1844852936 modified "2023-10-18" @default.
• W1844852936 title "Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status" @default.
• W1844852936 cites W1966566182 @default.
• W1844852936 cites W1976806852 @default.
• W1844852936 cites W1990340849 @default.
• W1844852936 cites W1997367235 @default.
• W1844852936 cites W1998971866 @default.
• W1844852936 cites W2000425266 @default.
• W1844852936 cites W2003984225 @default.
• W1844852936 cites W2006797972 @default.
• W1844852936 cites W2010693203 @default.
• W1844852936 cites W2012127976 @default.
• W1844852936 cites W2013721931 @default.
• W1844852936 cites W2026338982 @default.
• W1844852936 cites W2044662583 @default.
• W1844852936 cites W2049444331 @default.
• W1844852936 cites W2051663161 @default.
• W1844852936 cites W2077259663 @default.
• W1844852936 cites W2084845277 @default.
• W1844852936 cites W2085757352 @default.
• W1844852936 cites W2087367550 @default.
• W1844852936 cites W2103427526 @default.
• W1844852936 cites W2105327099 @default.
• W1844852936 cites W2106454531 @default.
• W1844852936 cites W2111662961 @default.
• W1844852936 cites W2114570899 @default.
• W1844852936 cites W2126277347 @default.
• W1844852936 cites W2126426563 @default.
• W1844852936 cites W2133488997 @default.
• W1844852936 cites W2134045615 @default.
• W1844852936 cites W2137456063 @default.
• W1844852936 cites W2137583207 @default.
• W1844852936 cites W2139236349 @default.
• W1844852936 cites W2144154026 @default.
• W1844852936 cites W2145557475 @default.
• W1844852936 cites W2150092010 @default.
• W1844852936 cites W2153888645 @default.
• W1844852936 cites W2155301446 @default.
• W1844852936 cites W2164194749 @default.
• W1844852936 cites W2168554121 @default.
• W1844852936 cites W2169961966 @default.
• W1844852936 cites W2219978888 @default.
• W1844852936 doi "https://doi.org/10.1186/s13000-015-0339-4" @default.
• W1844852936 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4501046" @default.
• W1844852936 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26170125" @default.
• W1844852936 hasPublicationYear "2015" @default.
• W1844852936 type Work @default.
• W1844852936 sameAs 1844852936 @default.
• W1844852936 citedByCount "23" @default.
• W1844852936 countsByYear W18448529362015 @default.
• W1844852936 countsByYear W18448529362016 @default.
• W1844852936 countsByYear W18448529362017 @default.
• W1844852936 countsByYear W18448529362018 @default.
• W1844852936 countsByYear W18448529362019 @default.
• W1844852936 countsByYear W18448529362020 @default.
• W1844852936 countsByYear W18448529362021 @default.
• W1844852936 countsByYear W18448529362022 @default.
• W1844852936 countsByYear W18448529362023 @default.
• W1844852936 crossrefType "journal-article" @default.
• W1844852936 hasAuthorship W1844852936A5011356826 @default.
• W1844852936 hasAuthorship W1844852936A5026756619 @default.
• W1844852936 hasAuthorship W1844852936A5055525358 @default.
• W1844852936 hasAuthorship W1844852936A5064783608 @default.
• W1844852936 hasAuthorship W1844852936A5087132038 @default.
• W1844852936 hasBestOaLocation W18448529361 @default.
• W1844852936 hasConcept C104317684 @default.
• W1844852936 hasConcept C121608353 @default.
• W1844852936 hasConcept C126322002 @default.
• W1844852936 hasConcept C142724271 @default.
• W1844852936 hasConcept C143998085 @default.
• W1844852936 hasConcept C145059251 @default.
• W1844852936 hasConcept C150194340 @default.
• W1844852936 hasConcept C186836561 @default.
• W1844852936 hasConcept C204232928 @default.
• W1844852936 hasConcept C2776256026 @default.
• W1844852936 hasConcept C2777714996 @default.
• W1844852936 hasConcept C2779438470 @default.
• W1844852936 hasConcept C2781182431 @default.
• W1844852936 hasConcept C4692481 @default.
• W1844852936 hasConcept C48023723 @default.
• W1844852936 hasConcept C501734568 @default.
• W1844852936 hasConcept C502942594 @default.
• W1844852936 hasConcept C54355233 @default.
• W1844852936 hasConcept C71924100 @default.
• W1844852936 hasConcept C86803240 @default.
• W1844852936 hasConceptScore W1844852936C104317684 @default.
• W1844852936 hasConceptScore W1844852936C121608353 @default.
• W1844852936 hasConceptScore W1844852936C126322002 @default.
• W1844852936 hasConceptScore W1844852936C142724271 @default.
• W1844852936 hasConceptScore W1844852936C143998085 @default.
• W1844852936 hasConceptScore W1844852936C145059251 @default.
• W1844852936 hasConceptScore W1844852936C150194340 @default.

• next